Jungla

Jungla, Inc. was a San Francisco precision-medicine informatics startup founded in 2016 by Alexander Colavin and Carlos Araya. Backed by Andreessen Horowitz (a16z) and IndieBio, it built a cloud-based Functional Modeling Platform (FMP), also described as a Molecular Evidence Platform, that combined functional genomics, computational biophysics, cellular engineering, and machine learning to produce auditable predictive models for clinical genetic and genomic variant interpretation. Jungla emerged from stealth in 2018 and was acquired by Invitae Corporation in July 2019 (approximately $59M), where its technology augmented Invitae's Sherloc variant-classification approach. The company is now defunct; its original developer surface (jungla.io) is offline and no public API, documentation, or SDKs survive. This profile is a historical record surfaced from the a16z portfolio; it carries no live developer artifacts.

Jungla is profiled on the APIs.io network. Tagged areas include Company, Precision Medicine, Genomics, Bioinformatics, and Healthcare.

5.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyPrecision MedicineGenomicsBioinformaticsHealthcareMachine LearningClinical DiagnosticsDefunctAcquired

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 5.7/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.0 / 20
Commercial Clarity 0.0 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/jungla: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Source (apis.yml)

apis.yml Raw ↑
aid: jungla
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/jungla.png
name: Jungla
description: Jungla, Inc. was a San Francisco precision-medicine informatics startup founded in 2016 by Alexander Colavin
  and Carlos Araya. Backed by Andreessen Horowitz (a16z) and IndieBio, it built a cloud-based Functional Modeling Platform
  (FMP), also described as a Molecular Evidence Platform, that combined functional genomics, computational biophysics, cellular
  engineering, and machine learning to produce auditable predictive models for clinical genetic and genomic variant interpretation.
  Jungla emerged from stealth in 2018 and was acquired by Invitae Corporation in July 2019 (approximately $59M), where its
  technology augmented Invitae's Sherloc variant-classification approach. The company is now defunct; its original developer
  surface (jungla.io) is offline and no public API, documentation, or SDKs survive. This profile is a historical record surfaced
  from the a16z portfolio; it carries no live developer artifacts.
url: https://raw.githubusercontent.com/api-evangelist/jungla/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- a16z
- IndieBio
x-tier: stub
x-tier-reason: portfolio-lead
x-status: defunct
x-status-detail: Acquired by Invitae Corporation in July 2019; company wound down
x-acquired-by: Invitae Corporation
x-acquired-date: '2019-07-16'
x-acquired-amount-usd: 59000000
x-founded: '2016'
x-founders:
- Alexander Colavin
- Carlos Araya
x-industry: precision-medicine
x-archive-url: https://jungla.bio/
x-enrichment-note: 'Enrichment pipeline run 2026-07-19 found no live developer surface. Original domain jungla.io is dead;
  jungla.bio is a static memorial page ("Jungla Inc. (2016-2019)"); jungla.com is an unrelated outdoor-kitchen product. No
  OpenAPI, docs portal, SDKs, packages, MCP server, or well-known documents exist to harvest. Sources: GenomeWeb (stealth
  emergence), Crunchbase, PitchBook, Invitae/Jungla acquisition press releases (PRNewswire, SEC 8-K).'
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Precision Medicine
- Genomics
- Bioinformatics
- Healthcare
- Machine Learning
- Clinical Diagnostics
- Defunct
- Acquired
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence